← SynDRA
FLUMATINIB
SynDRA canonical compound SYN0038298 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | PDGFRB |
| Mechanism of action | Abl kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- Abl kinase inhibitor
- ABL1 INHIBITOR
- Tyrosine-protein kinase ABL inhibitor
- KIT INHIBITOR
- PDGFRB INHIBITOR
- Bcr-Abl kinase inhibitor
Drug classes
- Tyrosine Kinase Inhibitors
Cross-references
Synonyms
- Flumbatinib
- Hhgv-678
- HH-GV678
- HH-GV-678
- flumbatinib
- HHGV678
- Flumatinib free base
- HHGV-678
- R4009Y24AI
- 895519-90-1 (free base)
- 4-[(4-methylpiperazin-1-yl)methyl]-N-[6-methyl-5-[(4-pyridin-3-ylpyrimidin-2-yl)amino]pyridin-3-yl]-3-(trifluoromethyl)benzamide
- HHGV678 mesylate
- BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)-
- N-(6-methyl-5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)pyridin-3-yl)-4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)benzamide
- UNII-R4009Y24AI
- Hansoh Xinfu
- BENZAMIDE, 4-((4-METHYL-1-PIPERAZINYL)METHYL)-N-(6-METHYL-5-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINO)-3-PYRIDINYL)-3-(TRIFLUOROMETHYL)-
- flumatinib (pseudo INN)
- FLUMBATINIB [INN]
- FLUMATINIB [WHO-DD]
- GTPL9913
- SCHEMBL4883843
- CHEMBL3545413
- DTXSID60237779
- BCP23797
- EX-A3572
- VKB51990
- BDBM50529313
- NSC830368
- ZINC68244727
- CS-5550
- DB11904
- NSC-830368
- SB17192
- NCGC00378614-01
- 4-(4-Methylpiperazin-1-ylmethyl)-N-(6-methyl-5-(4-pyridin-3-ylpyrimidin-2-ylamino)pyridin-3-yl)-3-trifluoromethylbenzamide
- DA-33625
- HY-13904
Look up FLUMATINIB in the interactive SynDRA portal →